Ekaterina V. Kulchavenya
Abstract
The review of more than 50 domestic and foreign literary sources, concerning the sequelae of novel coronavirus infection that affect human genitourinary system and fertility potential, has been performed, which also demonstrates some treatment possibilities for the emerging complications. The review has made it possible to reach the following conclusion: COVID-19 is a multisystem disease that affects multiple organs; pathogen eradication does not mean full recovery, acute or chronic post-COVID syndrome usually develops. It is advisable to repeat the course of Selzinc Plus for prevention and treatment of novel coronavirus infection; Selzinc Plus should be used to protect or restore male fertility potential after novel coronavirus infection. COVID-19 can exacerbate the existing OAB or trigger the development of OAB. Trospium chloride (Spasmex) is the best drug for treatment of OAB in cases of exposure to polypharmacy or in elderly patients.
Key words: novel coronavirus infection, COVID, post-COVID syndrome, SARS-CoV-2, selenium, zinc, Selzinc, overactive bladder, OAB, trospium chloride, Spasmex.
About the Author
Ekaterina V. Kulchavenya 11 Novosibirsk Research Institute of Tuberculosis, Novosibirsk, Russia; Novosibirsk State Medical University, Novosibirsk, Russia; Medical center "Avicenna", Novosibirsk, Russia
References
1. Altmann DM, Boyton RJ. Decoding the unknowns in long covid. BMJ 2021; 372: n132. DOI: 10.1136/bmj.n132
2. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis Lond 2021; 53 (10): 737–54. DOI: 10.1080/23744235.2021.1924397
3. Bellan M, Soddu D, Balbo PE et al. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open 2021; 4 (1): e2036142. DOI: 10.1001/jamanetworkopen.2020.36142
4. Han X, Fan Y, Alwalid O, Li N et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology 2021; 299 (1): E177–E186. DOI: 10.1148/radiol.2021203153
5. Truffaut L, Demey L, Bruyneel AV et al. Post-discharge critical COVID-19 lung function related to severity of radiologic lung involvement at admission. Respir Res 2021; 22 (1): 29. DOI: 10.1186/s12931-021-01625-y
6. Zhao YM, Shang YM, Song WB et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19
survivors three months after recovery. EClinicalMedicine 2020; 25: 100463. DOI: 10.1016/j.eclinm.2020.100463
7. Liu D, Zhang W, Pan F et al. The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study. Respir Res 2020; 21 (1): 125. DOI: 10.1186/s12931-020-01385-1
8. Marvisi M, Ferrozzi F, Balzarini L et al. First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: Factors predicting fibrotic evolution. Int J Infect Dis 2020; 99: 485–8. DOI: 10.1016/j.ijid.2020.08.054
9. Wei J, Yang H, Lei P et al. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge. J Xray Sci Technol 2020; 28 (3): 383–9. DOI: 10.3233/XST-200685
10. Puntmann VO, Carerj ML, Wieters I et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 2020; 5 (11): 1265–73. DOI: 10.1001/jamacardio.2020.3557
11. Rajpal S, Tong MS, Borchers J et al. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol 2021; 6 (1): 116–8. DOI: 10.1001/jamacardio.2020.4916
12. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020; 324 (6): 603–5. DOI: 10.1001/jama.2020. 12603
13. Dennis A, Wamil M, Alberts J et al.; COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021; 11 (3): e048391. DOI: 10.1136/bmjopen-2020-048391
14. Huang C, Huang L, Wang Y et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397 (10270): 220–32. DOI: 10.1016/S0140-6736(20)32656-8
15. Liang L, Yang B, Jiang N et al. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J Korean Med Sci 2020; 35 (47): e418. DOI: 10.3346/jkms.2020.35.e418
16. Raman B, Cassar MP, Tunnicliffe EM et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 2021; 31: 100683. DOI: 10.1016/j.eclinm. 2020.100683
17. Carod-Artal FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol 2021; 72 (11): 384–96. English, Spanish. DOI: 10.33588/rn.7211.2021230
18. Nalbandian A et al. Post-acute COVID-19 syndrome. Nat Med 2021; 27 (4): 601–15. DOI: 10.1038/s41591-021-01283-z
19. Сорокина Т.М., Брагина Е.Е., Сорокина Е.А. и др. Влияние перенесенной инфекции COVID-19 на спермиологические показатели мужчин с нарушением фертильности. Андрология и генитальная хирургия. 2021; 22 (3): 25–33. DOI: 10.17650/1726-9784-2021-22-3-25-33
[Sorokina T.M., Bragina E.E., Sorokina E.A. et al. Vliianie perenesennoi infektsii COVID-19 na spermiologicheskie pokazateli muzhchin s narusheniem fertil'nosti. Andrologiia i genital'naia khirurgiia. 2021; 22 (3): 25–33. DOI: 10.17650/1726-9784-2021-22-3-25-33 (in Russian).]
20. Кульчавеня Е.В., Холтобин Д.П., Телина Е.В. и др. Особенности работы урологических отделений в пандемию COVID-19. Урология. 2022; 1: 35–40 DOI: 10.18565/urology.2022.1.35-40
[Kul'chavenia E.V., Kholtobin D.P., Telina E.V. et al. Osobennosti raboty urologicheskikh otdelenii v pandemiiu COVID-19. Urologiia. 2022; 1: 35–40 DOI: 10.18565/urology.2022.1.35-40 (in Russian).]
21. Кульчавеня Е.В., Холтобин Д.П., Телина Е.В. Влияние пандемии COVID-19 на работу урологических отделений. Урологические ведомости. 2022; 12 (1): 5–11. DOI: 10.17816/uroved97019
[Kul'chavenia E.V., Kholtobin D.P., Telina E.V. Vliianie pandemii COVID-19 na rabotu urologicheskikh otdelenii. Urologicheskie vedomosti. 2022; 12 (1): 5–11. DOI: 10.17816/uroved97019 (in Russian).]
22. Катибов М.И., Магомедов З.М., Алибеков М.М. и др. Острые урологические синдромы и заболевания у пациентов с COVID-19. Экспериментальная и клиническая урология. 2022; 15 (1): 148–54. DOI: 10.29188/2222-8543-2022-15-1-148-154
[Katibov M.I., Magomedov Z.M., Alibekov M.M. et al. Ostrye urologicheskie sindromy i zabolevaniia u patsientov s COVID-19. Eksperimental'naia i klinicheskaia urologiia. 2022; 15 (1): 148–54. DOI: 10.29188/2222-8543-2022-15-1-148-154 (in Russian).]
23. Ахвледиани Н.Д., Рева И.А., Чернушенко А.С., Пушкарь Д.Ю. Андрологические аспекты новой коронавирусной инфекции COVID-19. Урология. 2021; 6: 130–5. DOI: 10.18565/urology.2021.6.130-135
[Akhvlediani N.D., Reva I.A., Chernushenko A.S., Pushkar' D.Iu. Andrologicheskie aspekty novoi koronavirusnoi infektsii COVID-19. Urologiia. 2021; 6: 130–5. DOI: 10.18565/urology.2021.6.130-135 (in Russian).]
24. Деревянко Т.И., Придчин С.В. Геморрагический инфаркт яичка как осложнение COVID-19 (SARS-CoV-2). Экспериментальная и клиническая урология. 2021; 14 (2): 70–2. DOI: 10.29188/2222-8543-2021-14-2-70-72
[Derevianko T.I., Pridchin S.V. Gemorragicheskii infarkt iaichka kak oslozhnenie COVID-19 (SARS-CoV-2). Eksperimental'naia i klinicheskaia urologiia. 2021; 14 (2): 70–2. DOI: 10.29188/2222-8543-2021-14-2-70-72 (in Russian).]
25. Асфандияров Ф.Р., Круглов В.А., Выборнов С.В. и др. Постковидный транзиторный гипогонадизм и эректильная дисфункция. Экспериментальная и клиническая урология 2021; 14 (3): 112–8. DOI: 10.29188/2222-8543-2021-14-3-112-118
[Asfandiiarov F.R., Kruglov V.A., Vybornov S.V. et al. Postkovidnyi tranzitornyi gipogonadizm i erektil'naia disfunktsiia. Eksperimental'naia i klinicheskaia urologiia 2021; 14 (3): 112–8. DOI: 10.29188/2222-8543-2021-14-3-112-118 (in Russian).]
26. Камалов А.А., Мареев В.Ю., Орлова Я.А. и др. ОСобенности течения НОвой коронавирусной инфекции и ВАрианты ТЕрапии боЛЬных в зависимости от андрогенного статуса (ОСНОВАТЕЛЬ): андрогенный статус у мужчин с COVID-19 и его связь с течением заболевания. Урология. 2021; 6: 85–99. DOI: 10.18565/ urology.2021.6.85-99
[Kamalov A.A., Mareev V.Iu., Orlova Ia.A. et al. OSobennosti techeniia NOvoi koronavirusnoi infektsii i VArianty TErapii boL'nykh v zavisimosti ot androgennogo statusa (OSNOVATEL'): androgennyi status u muzhchin s COVID-19 i ego sviaz' s techeniem zabolevaniia. Urologiia. 2021; 6: 85–99. DOI: 10.18565/urology.2021.6.85-99 (in Russian).]
27. Перлин Д.В., Александров И.В., Шманев А.О. и др. Трансплантация почки от Covid-19-инфицированного трупного донора: каковы последствия для реципиентов? Урология. 2021; 4: 87–92. DOI: 10.18565/urology.2021.4.87-92
[Perlin D.V., Aleksandrov I.V., Shmanev A.O. et al. Transplantatsiia pochki ot Covid-19-infitsirovannogo trupnogo donora: kakovy posledstviia dlia retsipientov? Urologiia. 2021; 4: 87–92. DOI: 10.18565/urology.2021.4.87-92 (in Russian).]
28. Khoza LJ, Kumar P, Dube A et al. Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles. Int J Pharm 2022; 622: 121893. DOI: 10.1016/j.ijpharm.2022.121893
29. Jimeno-Almazán A. Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int J Environ Res Public Health 2021; 18 (10): 5329. DOI: 10.3390/ijerph18105329
30. Брижатюк Е.В., Шевченко С.Ю. Влияние образа жизни больного хроническим простатитом на ее качество. Вестник урологии. 2020; 8 (3): 13–7. DOI: 10.21886/2308-6424-2020-8-3-13-17
[Brizhatiuk E.V., Shevchenko S.Iu. Vliianie obraza zhizni bol'nogo khronicheskim prostatitom na ee kachestvo. Vestnik urologii. 2020; 8 (3): 13–7. DOI: 10.21886/2308-6424-2020-8-3-13-17 (in Russian).]
31. Курашова Н.А., Дашиев Б.Г., Колесников С.И., Колесникова Л.И. Репродуктивное здоровье мужчин и COVID-19. Урология. 2022; 2: 122–5. DOI: 10.18565/urology.2022.2.122-125
[Kurashova N.A., Dashiev B.G., Kolesnikov S.I., Kolesnikova L.I. Reproduktivnoe zdorov'e muzhchin i COVID-19. Urologiia. 2022; 2: 122–5. DOI: 10.18565/urology.2022.2.122-125 (in Russian).]
32. Корнеев И.А. Мужское бесплодие при оксидативном стрессе: пути решения проблемы. Урология. 2022; 1: 102–8. DOI: 10.18565/urology.2022.1.102-108
[Korneev I.A. Muzhskoe besplodie pri oksidativnom stresse: puti resheniia problemy. Urologiia. 2022; 1: 102–8. DOI: 10.18565/urology. 2022.1.102-108 (in Russian).]
33. Кульчавеня Е.В., Осадчий А.В. Эффективность сперматопротективной терапии на основе Селцинка плюс у больных туберкулезом предстательной железы. Consilium Medicum. 2016; 18 (7): 22–6. DOI: 10.26442/2075-1753_2016.7.22-26
[Kul'chavenia E.V., Osadchii A.V. Effektivnost' spermatoprotektivnoi terapii na osnove Seltsinka plius u bol'nykh tuberkulezom predstatel'noi zhelezy. Consilium Medicum. 2016; 18 (7): 22–6. DOI: 10.26442/2075-1753_2016.7.22-26 (in Russian).]
34. Сивков А.В., Ощепков В.Н., Евдокимов В.В. и др. Эффективность и безопасность препарата Селцинк Плюс у пациентов с хроническим неинфекционным простатитом и нарушениями фертильности. Consilium Medicum. 2011;13 (7): 5–9.
[Sivkov A.V., Oshchepkov V.N., Evdokimov V.V. i dr. Effektivnost' i bezopasnost' preparata Seltsink Plius u patsientov s khronicheskim neinfektsionnym prostatitom i narusheniiami fertil'nosti. Consilium Medicum. 2011;13 (7): 5–9 (in Russian).]
35. Mayor-Ibarguren A, Busca-Arenzana C, Robles-Marhuenda Á. A Hypothesis for the Possible Role of Zinc in the Immunological Pathways Related to COVID-19 Infection. Front Immunol 2020; 11: 1736. DOI: 10.3389/fimmu.2020.01736
36. URL: https://стопкороновирус.рф/news/20201024-1315.html
37. Iddir M, Brito A, Dingeo G et al. Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrient 2020; 12 (6): 1562. DOI: 10.3390/nu12061562
38. Aoki Y et al. Urinary incontinence in women. Nat Rev Dis Primers 2017; 3: 17042. DOI: 10.1038/nrdp.2017.42
39. Dhar N, Dhar S, Timar R et al. De Novo Urinary Symptoms Associated With COVID-19: COVID-19-Associated Cystitis. J Clin Med Res 2020; 12 (10): 681–2. DOI: 10.14740/jocmr4294
40. Берников А.Н., Куприянов Ю.А., Строганов Р.В. и др. Симптомы нижних мочевыводящих путей и COVID-19. Урология. 2021; 5: 78–83. DOI: 10.18565/urology.2021.5.78-83
[Bernikov A.N., Kupriianov Iu.A., Stroganov R.V. et al. Simptomy nizhnikh mochevyvodiashchikh putei i COVID-19. Urologiia. 2021; 5: 78–83. DOI: 10.18565/urology.2021.5.78-83 (in Russian).]
41. Desouky E. SARS-CoV-2 tropism: what urologists need to know. Afr J Urol 2021; 27 (1): 23. DOI: 10.1186/s12301-021-00126-0
42. Lamb LE, Timar R, Wills M et al. Long COVID and COVID-19-associated cystitis (CAC). Int Urol Nephrol 2022; 54 (1):17–21.
43. Ackermann M, Verleden SE, Kuehnel M et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; 383 (2): 120–8. DOI: 10.1056/NEJMoa2015432
44. Chu H, Chan JF, Yuen TT et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe 2020; 1 (1): e14-e23. DOI: 10.1016/S2666-5247(20)30004-5
45. Song E, Zhang C, Israelow B et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 2021; 218 (3): e20202135. DOI: 10.1084/jem.20202135
46. von Weyhern CH, Kaufmann I, Neff F, Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet 2020; 395 (10241): e109. DOI: 10.1016/S0140-6736(20)31282-4
47. Zhang BZ, Chu H, Han S et al. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res 2020; 30 (10): 928–31. DOI: 10.1038/s41422-020-0390-x
48. Lu Y, Li X, Geng D et al. Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study. EClinicalMedicine 2020; 25: 100484. DOI: 10.1016/j.eclinm.2020.100484
49. Paterson RW, Brown RL, Benjamin L et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 2020; 143 (10): 3104–20. DOI: 10.1093/brain/awaa240
50. Golomb MR. Neurological issues in COVID-19, summarized in verse. J Stroke Cerebrovasc Dis 2020 Aug; 29 (8): 104939. DOI: 10.1016/j.jstrokecerebrovasdis.2020.104939
51. Bonkat G (chair), Bruyere F, Cai T et al. EAU Guidelines Edn. presented at the EAU Annual Congress Milan Italy 2021. ISBN 978-94-92671-13-4
52. Kerdraon J, Robain G, Jeandel C et al; Groupe de recherche appliquée à la pelvi-périnéologie de la personne âgée (GRAPPPA). Traitement anticholinergique de l'hyperactivité vésicale de la personne âgée et ses impacts sur la cognition. Revue de la littérature. Prog Urol 2014; 24 (11): 672–81. DOI: 10.1016/j.purol.2014.06.003
53. Geoffrion R; UROGYNAECOLOGY COMMITTEE. Treatments for overactive bladder: focus on pharmacotherapy. J Obstet Gynaecol Can 2012; 34 (11): 1092–101. DOI: 10.1016/S1701-2163(16)35440-8
2. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis Lond 2021; 53 (10): 737–54. DOI: 10.1080/23744235.2021.1924397
3. Bellan M, Soddu D, Balbo PE et al. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open 2021; 4 (1): e2036142. DOI: 10.1001/jamanetworkopen.2020.36142
4. Han X, Fan Y, Alwalid O, Li N et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology 2021; 299 (1): E177–E186. DOI: 10.1148/radiol.2021203153
5. Truffaut L, Demey L, Bruyneel AV et al. Post-discharge critical COVID-19 lung function related to severity of radiologic lung involvement at admission. Respir Res 2021; 22 (1): 29. DOI: 10.1186/s12931-021-01625-y
6. Zhao YM, Shang YM, Song WB et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19
survivors three months after recovery. EClinicalMedicine 2020; 25: 100463. DOI: 10.1016/j.eclinm.2020.100463
7. Liu D, Zhang W, Pan F et al. The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study. Respir Res 2020; 21 (1): 125. DOI: 10.1186/s12931-020-01385-1
8. Marvisi M, Ferrozzi F, Balzarini L et al. First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: Factors predicting fibrotic evolution. Int J Infect Dis 2020; 99: 485–8. DOI: 10.1016/j.ijid.2020.08.054
9. Wei J, Yang H, Lei P et al. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge. J Xray Sci Technol 2020; 28 (3): 383–9. DOI: 10.3233/XST-200685
10. Puntmann VO, Carerj ML, Wieters I et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 2020; 5 (11): 1265–73. DOI: 10.1001/jamacardio.2020.3557
11. Rajpal S, Tong MS, Borchers J et al. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol 2021; 6 (1): 116–8. DOI: 10.1001/jamacardio.2020.4916
12. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020; 324 (6): 603–5. DOI: 10.1001/jama.2020. 12603
13. Dennis A, Wamil M, Alberts J et al.; COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021; 11 (3): e048391. DOI: 10.1136/bmjopen-2020-048391
14. Huang C, Huang L, Wang Y et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397 (10270): 220–32. DOI: 10.1016/S0140-6736(20)32656-8
15. Liang L, Yang B, Jiang N et al. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J Korean Med Sci 2020; 35 (47): e418. DOI: 10.3346/jkms.2020.35.e418
16. Raman B, Cassar MP, Tunnicliffe EM et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 2021; 31: 100683. DOI: 10.1016/j.eclinm. 2020.100683
17. Carod-Artal FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol 2021; 72 (11): 384–96. English, Spanish. DOI: 10.33588/rn.7211.2021230
18. Nalbandian A et al. Post-acute COVID-19 syndrome. Nat Med 2021; 27 (4): 601–15. DOI: 10.1038/s41591-021-01283-z
19. Сорокина Т.М., Брагина Е.Е., Сорокина Е.А. и др. Влияние перенесенной инфекции COVID-19 на спермиологические показатели мужчин с нарушением фертильности. Андрология и генитальная хирургия. 2021; 22 (3): 25–33. DOI: 10.17650/1726-9784-2021-22-3-25-33
[Sorokina T.M., Bragina E.E., Sorokina E.A. et al. Vliianie perenesennoi infektsii COVID-19 na spermiologicheskie pokazateli muzhchin s narusheniem fertil'nosti. Andrologiia i genital'naia khirurgiia. 2021; 22 (3): 25–33. DOI: 10.17650/1726-9784-2021-22-3-25-33 (in Russian).]
20. Кульчавеня Е.В., Холтобин Д.П., Телина Е.В. и др. Особенности работы урологических отделений в пандемию COVID-19. Урология. 2022; 1: 35–40 DOI: 10.18565/urology.2022.1.35-40
[Kul'chavenia E.V., Kholtobin D.P., Telina E.V. et al. Osobennosti raboty urologicheskikh otdelenii v pandemiiu COVID-19. Urologiia. 2022; 1: 35–40 DOI: 10.18565/urology.2022.1.35-40 (in Russian).]
21. Кульчавеня Е.В., Холтобин Д.П., Телина Е.В. Влияние пандемии COVID-19 на работу урологических отделений. Урологические ведомости. 2022; 12 (1): 5–11. DOI: 10.17816/uroved97019
[Kul'chavenia E.V., Kholtobin D.P., Telina E.V. Vliianie pandemii COVID-19 na rabotu urologicheskikh otdelenii. Urologicheskie vedomosti. 2022; 12 (1): 5–11. DOI: 10.17816/uroved97019 (in Russian).]
22. Катибов М.И., Магомедов З.М., Алибеков М.М. и др. Острые урологические синдромы и заболевания у пациентов с COVID-19. Экспериментальная и клиническая урология. 2022; 15 (1): 148–54. DOI: 10.29188/2222-8543-2022-15-1-148-154
[Katibov M.I., Magomedov Z.M., Alibekov M.M. et al. Ostrye urologicheskie sindromy i zabolevaniia u patsientov s COVID-19. Eksperimental'naia i klinicheskaia urologiia. 2022; 15 (1): 148–54. DOI: 10.29188/2222-8543-2022-15-1-148-154 (in Russian).]
23. Ахвледиани Н.Д., Рева И.А., Чернушенко А.С., Пушкарь Д.Ю. Андрологические аспекты новой коронавирусной инфекции COVID-19. Урология. 2021; 6: 130–5. DOI: 10.18565/urology.2021.6.130-135
[Akhvlediani N.D., Reva I.A., Chernushenko A.S., Pushkar' D.Iu. Andrologicheskie aspekty novoi koronavirusnoi infektsii COVID-19. Urologiia. 2021; 6: 130–5. DOI: 10.18565/urology.2021.6.130-135 (in Russian).]
24. Деревянко Т.И., Придчин С.В. Геморрагический инфаркт яичка как осложнение COVID-19 (SARS-CoV-2). Экспериментальная и клиническая урология. 2021; 14 (2): 70–2. DOI: 10.29188/2222-8543-2021-14-2-70-72
[Derevianko T.I., Pridchin S.V. Gemorragicheskii infarkt iaichka kak oslozhnenie COVID-19 (SARS-CoV-2). Eksperimental'naia i klinicheskaia urologiia. 2021; 14 (2): 70–2. DOI: 10.29188/2222-8543-2021-14-2-70-72 (in Russian).]
25. Асфандияров Ф.Р., Круглов В.А., Выборнов С.В. и др. Постковидный транзиторный гипогонадизм и эректильная дисфункция. Экспериментальная и клиническая урология 2021; 14 (3): 112–8. DOI: 10.29188/2222-8543-2021-14-3-112-118
[Asfandiiarov F.R., Kruglov V.A., Vybornov S.V. et al. Postkovidnyi tranzitornyi gipogonadizm i erektil'naia disfunktsiia. Eksperimental'naia i klinicheskaia urologiia 2021; 14 (3): 112–8. DOI: 10.29188/2222-8543-2021-14-3-112-118 (in Russian).]
26. Камалов А.А., Мареев В.Ю., Орлова Я.А. и др. ОСобенности течения НОвой коронавирусной инфекции и ВАрианты ТЕрапии боЛЬных в зависимости от андрогенного статуса (ОСНОВАТЕЛЬ): андрогенный статус у мужчин с COVID-19 и его связь с течением заболевания. Урология. 2021; 6: 85–99. DOI: 10.18565/ urology.2021.6.85-99
[Kamalov A.A., Mareev V.Iu., Orlova Ia.A. et al. OSobennosti techeniia NOvoi koronavirusnoi infektsii i VArianty TErapii boL'nykh v zavisimosti ot androgennogo statusa (OSNOVATEL'): androgennyi status u muzhchin s COVID-19 i ego sviaz' s techeniem zabolevaniia. Urologiia. 2021; 6: 85–99. DOI: 10.18565/urology.2021.6.85-99 (in Russian).]
27. Перлин Д.В., Александров И.В., Шманев А.О. и др. Трансплантация почки от Covid-19-инфицированного трупного донора: каковы последствия для реципиентов? Урология. 2021; 4: 87–92. DOI: 10.18565/urology.2021.4.87-92
[Perlin D.V., Aleksandrov I.V., Shmanev A.O. et al. Transplantatsiia pochki ot Covid-19-infitsirovannogo trupnogo donora: kakovy posledstviia dlia retsipientov? Urologiia. 2021; 4: 87–92. DOI: 10.18565/urology.2021.4.87-92 (in Russian).]
28. Khoza LJ, Kumar P, Dube A et al. Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles. Int J Pharm 2022; 622: 121893. DOI: 10.1016/j.ijpharm.2022.121893
29. Jimeno-Almazán A. Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int J Environ Res Public Health 2021; 18 (10): 5329. DOI: 10.3390/ijerph18105329
30. Брижатюк Е.В., Шевченко С.Ю. Влияние образа жизни больного хроническим простатитом на ее качество. Вестник урологии. 2020; 8 (3): 13–7. DOI: 10.21886/2308-6424-2020-8-3-13-17
[Brizhatiuk E.V., Shevchenko S.Iu. Vliianie obraza zhizni bol'nogo khronicheskim prostatitom na ee kachestvo. Vestnik urologii. 2020; 8 (3): 13–7. DOI: 10.21886/2308-6424-2020-8-3-13-17 (in Russian).]
31. Курашова Н.А., Дашиев Б.Г., Колесников С.И., Колесникова Л.И. Репродуктивное здоровье мужчин и COVID-19. Урология. 2022; 2: 122–5. DOI: 10.18565/urology.2022.2.122-125
[Kurashova N.A., Dashiev B.G., Kolesnikov S.I., Kolesnikova L.I. Reproduktivnoe zdorov'e muzhchin i COVID-19. Urologiia. 2022; 2: 122–5. DOI: 10.18565/urology.2022.2.122-125 (in Russian).]
32. Корнеев И.А. Мужское бесплодие при оксидативном стрессе: пути решения проблемы. Урология. 2022; 1: 102–8. DOI: 10.18565/urology.2022.1.102-108
[Korneev I.A. Muzhskoe besplodie pri oksidativnom stresse: puti resheniia problemy. Urologiia. 2022; 1: 102–8. DOI: 10.18565/urology. 2022.1.102-108 (in Russian).]
33. Кульчавеня Е.В., Осадчий А.В. Эффективность сперматопротективной терапии на основе Селцинка плюс у больных туберкулезом предстательной железы. Consilium Medicum. 2016; 18 (7): 22–6. DOI: 10.26442/2075-1753_2016.7.22-26
[Kul'chavenia E.V., Osadchii A.V. Effektivnost' spermatoprotektivnoi terapii na osnove Seltsinka plius u bol'nykh tuberkulezom predstatel'noi zhelezy. Consilium Medicum. 2016; 18 (7): 22–6. DOI: 10.26442/2075-1753_2016.7.22-26 (in Russian).]
34. Сивков А.В., Ощепков В.Н., Евдокимов В.В. и др. Эффективность и безопасность препарата Селцинк Плюс у пациентов с хроническим неинфекционным простатитом и нарушениями фертильности. Consilium Medicum. 2011;13 (7): 5–9.
[Sivkov A.V., Oshchepkov V.N., Evdokimov V.V. i dr. Effektivnost' i bezopasnost' preparata Seltsink Plius u patsientov s khronicheskim neinfektsionnym prostatitom i narusheniiami fertil'nosti. Consilium Medicum. 2011;13 (7): 5–9 (in Russian).]
35. Mayor-Ibarguren A, Busca-Arenzana C, Robles-Marhuenda Á. A Hypothesis for the Possible Role of Zinc in the Immunological Pathways Related to COVID-19 Infection. Front Immunol 2020; 11: 1736. DOI: 10.3389/fimmu.2020.01736
36. URL: https://стопкороновирус.рф/news/20201024-1315.html
37. Iddir M, Brito A, Dingeo G et al. Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrient 2020; 12 (6): 1562. DOI: 10.3390/nu12061562
38. Aoki Y et al. Urinary incontinence in women. Nat Rev Dis Primers 2017; 3: 17042. DOI: 10.1038/nrdp.2017.42
39. Dhar N, Dhar S, Timar R et al. De Novo Urinary Symptoms Associated With COVID-19: COVID-19-Associated Cystitis. J Clin Med Res 2020; 12 (10): 681–2. DOI: 10.14740/jocmr4294
40. Берников А.Н., Куприянов Ю.А., Строганов Р.В. и др. Симптомы нижних мочевыводящих путей и COVID-19. Урология. 2021; 5: 78–83. DOI: 10.18565/urology.2021.5.78-83
[Bernikov A.N., Kupriianov Iu.A., Stroganov R.V. et al. Simptomy nizhnikh mochevyvodiashchikh putei i COVID-19. Urologiia. 2021; 5: 78–83. DOI: 10.18565/urology.2021.5.78-83 (in Russian).]
41. Desouky E. SARS-CoV-2 tropism: what urologists need to know. Afr J Urol 2021; 27 (1): 23. DOI: 10.1186/s12301-021-00126-0
42. Lamb LE, Timar R, Wills M et al. Long COVID and COVID-19-associated cystitis (CAC). Int Urol Nephrol 2022; 54 (1):17–21.
43. Ackermann M, Verleden SE, Kuehnel M et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; 383 (2): 120–8. DOI: 10.1056/NEJMoa2015432
44. Chu H, Chan JF, Yuen TT et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe 2020; 1 (1): e14-e23. DOI: 10.1016/S2666-5247(20)30004-5
45. Song E, Zhang C, Israelow B et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 2021; 218 (3): e20202135. DOI: 10.1084/jem.20202135
46. von Weyhern CH, Kaufmann I, Neff F, Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet 2020; 395 (10241): e109. DOI: 10.1016/S0140-6736(20)31282-4
47. Zhang BZ, Chu H, Han S et al. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res 2020; 30 (10): 928–31. DOI: 10.1038/s41422-020-0390-x
48. Lu Y, Li X, Geng D et al. Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study. EClinicalMedicine 2020; 25: 100484. DOI: 10.1016/j.eclinm.2020.100484
49. Paterson RW, Brown RL, Benjamin L et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 2020; 143 (10): 3104–20. DOI: 10.1093/brain/awaa240
50. Golomb MR. Neurological issues in COVID-19, summarized in verse. J Stroke Cerebrovasc Dis 2020 Aug; 29 (8): 104939. DOI: 10.1016/j.jstrokecerebrovasdis.2020.104939
51. Bonkat G (chair), Bruyere F, Cai T et al. EAU Guidelines Edn. presented at the EAU Annual Congress Milan Italy 2021. ISBN 978-94-92671-13-4
52. Kerdraon J, Robain G, Jeandel C et al; Groupe de recherche appliquée à la pelvi-périnéologie de la personne âgée (GRAPPPA). Traitement anticholinergique de l'hyperactivité vésicale de la personne âgée et ses impacts sur la cognition. Revue de la littérature. Prog Urol 2014; 24 (11): 672–81. DOI: 10.1016/j.purol.2014.06.003
53. Geoffrion R; UROGYNAECOLOGY COMMITTEE. Treatments for overactive bladder: focus on pharmacotherapy. J Obstet Gynaecol Can 2012; 34 (11): 1092–101. DOI: 10.1016/S1701-2163(16)35440-8
For citation:Kulchavenya E.V. Post-COVID syndrome in urology. Clinical review for general practice. 2022; 4: 66–72. DOI: 10.47407/kr2022.3.4.00154
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.